1.0k total citations 14 papers, 836 citations indexed
About
C Lavignac is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology.
According to data from OpenAlex, C Lavignac has authored 14 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in C Lavignac's work include Vasculitis and related conditions (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Urticaria and Related Conditions (2 papers). C Lavignac is often cited by papers focused on Vasculitis and related conditions (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Urticaria and Related Conditions (2 papers). C Lavignac collaborates with scholars based in France. C Lavignac's co-authors include Josette Brière, Olivier Hermine, Éric Lepage, Corinne Haïoun, Philippe Gaulard, Marolleau Jp, J Diébold, Gilles Salles, Georges Fillet and É. Liozon and has published in prestigious journals such as Blood, Human Immunology and La Revue de Médecine Interne.
In The Last Decade
C Lavignac
14 papers
receiving
806 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of C Lavignac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Lavignac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Lavignac more than expected).
This network shows the impact of papers produced by C Lavignac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Lavignac. The network helps show where C Lavignac may publish in the future.
Co-authorship network of co-authors of C Lavignac
This figure shows the co-authorship network connecting the top 25 collaborators of C Lavignac.
A scholar is included among the top collaborators of C Lavignac based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C Lavignac. C Lavignac is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Hermine, Olivier, et al.. (1996). ROGNOSTIC SIGNIFICANCE OF BCL2 EXPRESSION IN AGGRESSIVE NON-HODGKIN’S LYMPHOMA. GROUPE D’ ETADE DES LYMPHOMAS DE L’ADULTE GELA. 87(1). 265–272.5 indexed citations
Liozon, F, C Lavignac, D Émilie, et al.. (1993). [Immunohistochemical study of lesions of temporal arteritis in Horton's disease].. PubMed. 144(2). 85–91.3 indexed citations
11.
Vidal, Éric, F. Gaches, C Lavignac, et al.. (1993). Vascularite après vaccin antigrippal. La Revue de Médecine Interne. 14(10). 1173–1173.2 indexed citations
12.
Frindel, E, Aline Massé, Léonid Volkov, C Lavignac, & Michel Rigaud. (1992). Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part I. MLR with mouse spleen cells.. PubMed. 6(10). 1043–4.2 indexed citations
13.
Lavignac, C, Léonid Volkov, Aline Massé, Michel Rigaud, & E Frindel. (1992). Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part II. Human whole blood cells.. PubMed. 6(10). 1045–7.2 indexed citations
14.
Lebargy, F., C Lavignac, Philippe Gaulard, et al.. (1991). Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines.. PubMed. 84(3). 415–21.7 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.